Eligibility typically requires a BMI 35 kg/m (or 32.5 kg/m in people from certain ethnic groups), or a BMI 30 kg/m with weight-related comorbidities, alongside engagement with lifestyle modification programmes
The freeze-thaw cycle destroys peptide structure and eliminates therapeutic activity
Immunoblot analysis of total (T), pellet 1 (P1), supernatant 1 (S1), pellet 2 (P2) and supernatant 2 (S2) fractions using anti-SLC33A1 antibody at 1:5,000 dilution
Also, the break-even point has increased to 4,000 units and both the P/V ratio and MOS ratio have fallen
Side effects Side effects may include: bleeding skin infection at the site of injection increased appetite flushed face menstrual irregularities temporary increase in blood sugar diarrhea nausea More serious complications may include: infection damage to nerves spinal headache weakened muscles increase in pain death of bone tissue, called avascular necrosis a pain disorder called arachnoiditis paralysis Doctors do not use discographies often